PD-1 INHIBITOR
Clinical trials for PD-1 INHIBITOR explained in plain language.
Never miss a new study
Get alerted when new PD-1 INHIBITOR trials appear
Sign up with your email to follow new studies for PD-1 INHIBITOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy hopes to boost immune attack on tough pancreatic cancer
Disease control Recruiting nowThis study tests whether adding low-dose radiation and an immunotherapy drug (pultelimab) to standard treatment can help shrink tumors in people with advanced pancreatic cancer. About 10 adults who have not had immunotherapy before will take part. The goal is to see if the combin…
Matched conditions: PD-1 INHIBITOR
Phase: PHASE1, PHASE2 • Sponsor: Zhejiang Provincial People's Hospital • Aim: Disease control
Last updated May 26, 2026 10:47 UTC
-
New combo may treat kidney cancer without removing the organ
Disease control Recruiting nowThis study tests whether a combination of two drugs (tislelizumab and nab-paclitaxel) can treat renal pelvic cancer while avoiding removal of the kidney. About 35 adults with early-stage cancer that hasn't spread will receive the drugs, and if the tumor shrinks enough, they may g…
Matched conditions: PD-1 INHIBITOR
Phase: PHASE2 • Sponsor: Tianjin Medical University Second Hospital • Aim: Disease control
Last updated May 26, 2026 10:34 UTC